0BO vs LP6: Side-by-Side Comparison
Compare Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) and LIVZON PHARMAC. GRP H YC1 (LP6) side by side: market cap EUR 38.83B vs EUR 2.52B, P/E 36.6 vs 9.8. Financials, growth and model signals on Bullrun.
| Metric | 0BO | LP6 |
|---|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | LIVZON PHARMAC. GRP H YC1 |
| Country / Exchange | China · F | China · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 38.83B | EUR 2.52B |
| P/E ratio | 36.6 | 9.8 |
| Dividend yield | 0.43% | 7.01% |
| Valuation model | 24.2% overvalued | 21.7% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |